Clinical Trials List
2021-10-20 - 2025-04-30
Phase II
Recruiting3
ICD-10K51.90
Ulcerative colitis, unspecified, without complications
ICD-10K51.911
Ulcerative colitis, unspecified with rectal bleeding
ICD-10K51.912
Ulcerative colitis, unspecified with intestinal obstruction
ICD-10K51.913
Ulcerative colitis, unspecified with fistula
ICD-10K51.914
Ulcerative colitis, unspecified with abscess
ICD-10K51.918
Ulcerative colitis, unspecified with other complication
ICD-10K51.919
Ulcerative colitis, unspecified with unspecified complications
ICD-9556.9
Ulcerative colitis, unspecified
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 王彥博 Division of General Internal Medicine
- Hung-Hsin Lin Division of General Surgery
- 張天恩 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 謝銘鈞 Division of Hematology & Oncology
- 吳嘉峰 Division of Pediatrics
- CHIEN-CHIH TUNG Division of Family Medicine
- YEN-HSUAN NI Division of Pediatrics
- Huey-Ling Chen Division of Pediatrics
- 翁孟慈 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Tsung-Yu Tsai Division of General Internal Medicine
- 蔡元耀 Division of General Surgery
- 吳宜樺 Division of General Internal Medicine
- 張安迪 Division of General Internal Medicine
- 黃柏儒 Division of General Internal Medicine
- Chun-Lung Feng Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
3 participants
-
Global
240 participants
